gender-affirming hormone therapy

From Aaushi
Jump to navigation Jump to search

Epidemiology

Indications

Adverse effects

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018
  2. Hembree WC, Cohen-Kettenis PT, Gooren L et al Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28945902
  3. Safer JD, Tangpricha V. Care of Transgender Persons. N Engl J Med. 2019 Dec 19;381(25):2451-2460. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31851801 Review. No abstract available. https://www.nejm.org/doi/pdf/10.1056/NEJMcp1903650
  4. NEJM Knowledge+ Endocrinology